RhoJ: an emerging biomarker and target in cancer research and treatment

J Shen, X Su, S Wang, Z Wang, C Zhong… - Cancer Gene …, 2024 - nature.com
Abstract RhoJ is a Rho GTPase that belongs to the Cdc42 subfamily and has a molecular
weight of approximately 21 kDa. It can activate the p21-activated kinase family either directly …
相关文章

RhoJ: an emerging biomarker and target in cancer research and treatment.

J Shen, X Su, S Wang, Z Wang, C Zhong… - Cancer Gene …, 2024 - europepmc.org
RhoJ is a Rho GTPase that belongs to the Cdc42 subfamily and has a molecular weight of
approximately 21 kDa. It can activate the p21-activated kinase family either directly or …

RhoJ: an emerging biomarker and target in cancer research and treatment

J Shen, X Su, S Wang, Z Wang, C Zhong… - Cancer gene … - pubmed.ncbi.nlm.nih.gov
RhoJ is a Rho GTPase that belongs to the Cdc42 subfamily and has a molecular weight of
approximately 21 kDa. It can activate the p21-activated kinase family either directly or …